Search Results - Sonia Rodrı́guez-Nóvoa
- Showing 1 - 12 results of 12
-
1
-
2
-
3
-
4
Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1 by Sonia Rodríguez‐Nóvoa, Pablo Barreiro, A. Rendon, A. Barrios, Angélica Corral, Inmaculada Jiménez-Nàcher, J. Gonzalez-Lahoz, Vincent Soriano
Published 2005Artigo -
5
Influence of Liver Fibrosis Stage on Plasma Levels of Antiretroviral Drugs in HIV‐Infected Patients with Chronic Hepatitis C by Pablo Barreiro, Sonia Rodrı́guez-Nóvoa, Pablo Labarga, A. Guerra Ruiz, Inmaculada Jiménez‐Nácher, Luz Martín‐Carbonero, Juan González‐Lahoz, Vincent Soriano
Published 2007Artigo -
6
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations by Sonia Rodríguez‐Nóvoa, Pablo Labarga, Antonio D’Avolio, Pablo Barreiro, Marta Albalate, Eugenia Vispo, Carmen Solera, Marco Siccardi, Stefano Bonora, Giovanni Di Perri, Vincent Soriano
Published 2010Artigo -
7
Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study by Sonia Rodríguez‐Nóvoa, Pablo Labarga, Vincent Soriano, Deirdre Egan, Marta Albalater, Judit Morelló, Lorena Cuenca‐Bermejo, Gema González‐Pardo, Saye Khoo, David Back, Andrew Owen
Published 2009Artigo -
8
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir by Pablo Labarga, Pablo Barreiro, Luz Martín‐Carbonero, Sonia Rodrı́guez-Nóvoa, Carmen Solera, J. Medraño, Pablo Rivas, Marta Albalater, Francisco J. Blanco, V. Moreno, Eugenia Vispo, Vincent Soriano
Published 2009Artigo -
9
Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction by Sudeep Pushpakom, Neill J. Liptrott, Sonia Rodríguez‐Nóvoa, Pablo Labarga, Vincent Soriano, Marta Albalater, Elizabeth Hopper-Borge, Stefano Bonora, Giovanni Di Perri, David Back, Saye Khoo, Munir Pirmohamed, Andrew Owen
Published 2011Artigo -
10
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial by Vincent Soriano, Pilar García‐Gascó, Eugenia Vispo, Andrés Ruiz-Sancho, Francisco J. Blanco, Luz Martín‐Carbonero, Sonia Rodríguez‐Nóvoa, Judit Morelló, Carmen de Mendoza, Pedro Rivas, Pablo Barreiro, J. Gonzalez-Lahoz
Published 2007Artigo -
11
Low Response to Pegylated Interferon plus Ribavirin in HIV-Infected Patients with Chronic Hepatitis C Treated with Abacavir by Eugenia Vispo, Pablo Barreiro, Juan A. Pineda, José Antonio López Mira, Ivana Maida, Luz Martín‐Carbonero, Sonia Rodrı́guez-Nóvoa, Ignacio de los Santos, Luís F. López‐Cortés, Dolores Merino, Antonio Rivero, Vincent Soriano
Published 2008Artigo -
12
Population Pharmacokinetic Modeling of the Association between 63396C→T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance by Alessandro Schipani, Marco Siccardi, Antonio D’Avolio, Lorena Baietto, Marco Simiele, Stefano Bonora, Sonia Rodríguez‐Nóvoa, Lorena Cuenca‐Bermejo, Vincent Soriano, Nitipatana Chierakul, Natpratou Saguenwong, Charoen Chuchuttaworn, Janelle M. Hoskins, Anne Dvorak, Howard L. McLeod, Geraint Davies, Saye Khoo, David Back, Giovanni Di Perri, Andrew Owen
Published 2010Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Antiretroviral therapy
Human immunodeficiency virus (HIV)
Viral load
Virology
Gastroenterology
Pharmacology
Atazanavir
Biology
Gene
Genetics
Genotype
Hepatitis C
Immunology
Odds ratio
Renal function
Biochemistry
Confidence interval
Efavirenz
Kidney
Lopinavir
Pegylated interferon
Plasma concentration
Ribavirin
Ritonavir
Tenofovir
Urology
Virus
Abacavir